SCHEDULE: State Street Corp Discloses Recursion Pharmaceuticals Stake

State Street Corporation has filed a Schedule 13G, reporting beneficial ownership of 6.6% of Recursion Pharmaceuticals Inc. common stock as of June 30, 2026.

Summary

• State Street Corporation has filed a Schedule 13G, indicating its beneficial ownership of Recursion Pharmaceuticals Inc. common stock.
• As of June 30, 2026, State Street Corporation beneficially owned 34,706,130 shares, representing 6.6% of the class of securities.
• The filing specifies that State Street Corporation has sole voting power of 0 shares and shared voting power of 33,433,905 shares.
• For disposition, State Street Corporation has sole power of 0 shares and shared power of 34,706,130 shares.
• The filing is made by State Street Corporation, a Massachusetts-based entity, and is classified as a holding company (HC).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it primarily reports on changes in beneficial ownership by a large institutional investor and does not contain new operational or financial performance data.

Positives

• State Street Corporation's filing confirms a significant institutional holding, which can be seen as a vote of confidence in the company's long-term prospects.
• The disclosure provides transparency regarding the ownership structure of Recursion Pharmaceuticals Inc.

Negatives

• The filing does not provide any new operational or financial performance data for Recursion Pharmaceuticals Inc., limiting insights into the company's current health.
• The large number of shares with shared disposition power could indicate potential for future selling pressure, though this is typical for institutional holdings.

Risks

• The filing does not explicitly mention any new risks or challenges for Recursion Pharmaceuticals Inc.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding Recursion Pharmaceuticals Inc.'s future performance.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that institutional ownership filings like this Schedule 13G are common for publicly traded companies. The disclosure by State Street Corporation, a major custodian and asset manager, indicates a significant passive investment in Recursion Pharmaceuticals Inc., a company operating in the biotechnology and drug discovery sector.

Stakeholder Impact

• Shareholders: Provides transparency on a significant institutional investor's holdings, potentially influencing market perception.
• Management: The filing confirms that the shares are held in the ordinary course of business and not for the purpose of influencing control.

Next Steps

• State Street Corporation will continue to hold its position in Recursion Pharmaceuticals Inc. unless further filings indicate changes in beneficial ownership.

Key Dates

Keywords

State Street Corporation, Recursion Pharmaceuticals, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Ownership Disclosure